We are currently developing a range of AI-Driven and Computational Platforms to tackle complex Bioinformatics challenges. You are invited to explore our innovative initiatives and contribute through Investment, Expertise, or Advisory Support.
AI-ENZO is an enzyme optimization platform currently in development, aimed at revolutionising traditional synthesis technologies by leveraging AI and computational methods to deliver swift and efficient industrial solutions.
*AI-ENZO will be available for use after AI action Summit France 2025.
AI-ENZO has been selected as one of the top 35 AI-Convergence Challenges for the upcoming AI Action Summit in France.
Read Press Release
We aim to commercialise and launch AI-ENZO in France and are seeking investors and founders skilled in French legal and regulatory systems.
Apply below.
We seek experts in Artificial Intelligence, Synthetic Chemistry, Structural Bioinformatics, and Programming
Apply below.
ENZO is functional which can be used for your projects to modify proteins or enzymes and identify potential mutants.
Apply below.
You must be logged in to post a comment.